Table 7.

Age-adjusted incidence rates of malignancies in donors compared with the US general population: BM donors vs US general population (SEER)

OutcomesBM donorsUS general
population (SEER)
Rate ratio (95% CI)P value
Person- yearsNo. of eventsIncidence rate (95% CI)Person-yearsNo. of eventsIncidence rate (95% CI)
Myeloid 72 641 4.13 (1.33-12.8) 2 211 987 365 396 134 17.91 (17.85-17.96) 0.23 (0.07-0.72) .011  
Lymphoid 72 572 10 13.78 (7.41-25.61) 2 211 987 365 746 740 33.76 (33.68-33.84) 0.41 (0.22-0.76) .005  
Other malignancies 70 553 368 521.59 (471.1-577.6) 2 211 987 365 12 569 821 568.3 (567.9-568.6) 0.92 (0.83-1.02) .100 
OutcomesBM donorsUS general
population (SEER)
Rate ratio (95% CI)P value
Person- yearsNo. of eventsIncidence rate (95% CI)Person-yearsNo. of eventsIncidence rate (95% CI)
Myeloid 72 641 4.13 (1.33-12.8) 2 211 987 365 396 134 17.91 (17.85-17.96) 0.23 (0.07-0.72) .011  
Lymphoid 72 572 10 13.78 (7.41-25.61) 2 211 987 365 746 740 33.76 (33.68-33.84) 0.41 (0.22-0.76) .005  
Other malignancies 70 553 368 521.59 (471.1-577.6) 2 211 987 365 12 569 821 568.3 (567.9-568.6) 0.92 (0.83-1.02) .100 

Age-adjusted incidence rate per 100 000 person-years.

Result is statistically significant (P < .05).

or Create an Account

Close Modal
Close Modal